Subject: File No. SR-NSCC-2021-801
From: Eric Lang
Affiliation: Clinical Research Coordinator

April 9, 2021

Transparency is essential to maintain faith in US markets. With the knowledge of OTC markets, illegal market activity patterns, and the complexities of shorting (and lacking regulations) being introduced to the public, the integrity of our markets is brought into question. This rule will help improve transparency, but it is not a panacea. The remaining rules filed by the DTCC, that are awaiting a decision by the SEC, will also improve transparency but also are not a panacea, even when their effects are combined. The SEC MUST do even more to maintain the integrity of our markets. Approving these rules is a good start, but I hope to see more going forward.